Skip to main content
Top
Published in: Breast Cancer Research 5/2002

01-10-2002 | Commentary

Familial risks of breast cancer

Author: Douglas F Easton

Published in: Breast Cancer Research | Issue 5/2002

Login to get access

Abstract

A recent analysis by the Collaborative Group on Hormonal Factors in Breast Cancer has provided the most precise quantification to date of the familial risks of breast cancer. The familial relative risks are shown to decrease from more than fivefold in women younger than age 40 years with a first-degree relative aged younger than 40 years at diagnosis, to 1.4-fold in women older than 60 years with a relative diagnosed over age 60 years. These risks increase progressively with the number of affected relatives. The risks associated with an affected mother and an affected sister are similar, and the relative (but not absolute) risks are similar in subgroups defined by other established breast cancer risk factors. These results provide a useful basis for counselling of women with a family history of breast cancer, and they have implications for the genetic basis of the disease.
Literature
1.
go back to reference Collaborative Group on Hormonal Factors in Breast Cancer: Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58209 women with breast cancer and 101986 women without the disease. Lancet. 2001, 358: 1389-1399. 10.1016/S0140-6736(01)06524-2.CrossRef Collaborative Group on Hormonal Factors in Breast Cancer: Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58209 women with breast cancer and 101986 women without the disease. Lancet. 2001, 358: 1389-1399. 10.1016/S0140-6736(01)06524-2.CrossRef
2.
go back to reference Claus EB, Risch N, Thompson WD: Age of onset as an indicator of familial risk of breast cancer. Am J Epidemiol. 1990, 131: 961-972.PubMed Claus EB, Risch N, Thompson WD: Age of onset as an indicator of familial risk of breast cancer. Am J Epidemiol. 1990, 131: 961-972.PubMed
3.
go back to reference Hemminki K, Vaittinen P: Familial cancers in a nation-wide family-cancer database: age distribution and prevalence. Eur J Cancer. 1999, 35: 1109-1117. 10.1016/S0959-8049(99)00066-0.CrossRefPubMed Hemminki K, Vaittinen P: Familial cancers in a nation-wide family-cancer database: age distribution and prevalence. Eur J Cancer. 1999, 35: 1109-1117. 10.1016/S0959-8049(99)00066-0.CrossRefPubMed
4.
go back to reference Peto J, Easton DF, Matthews FE, Ford D, Swerdlow AJ: Cancer mortality in relatives of women with breast cancer: the OPCS study. Int J Cancer. 1996, 65: 275-283. 10.1002/(SICI)1097-0215(19960126)65:3<275::AID-IJC1>3.0.CO;2-X.CrossRefPubMed Peto J, Easton DF, Matthews FE, Ford D, Swerdlow AJ: Cancer mortality in relatives of women with breast cancer: the OPCS study. Int J Cancer. 1996, 65: 275-283. 10.1002/(SICI)1097-0215(19960126)65:3<275::AID-IJC1>3.0.CO;2-X.CrossRefPubMed
5.
go back to reference Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR: The prevalence of BRCA1 and BRCA2 mutations amongst early onset breast cancer cases in the U.K. J Natl Cancer Inst. 1999, 91: 943-949. 10.1093/jnci/91.11.943.CrossRefPubMed Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR: The prevalence of BRCA1 and BRCA2 mutations amongst early onset breast cancer cases in the U.K. J Natl Cancer Inst. 1999, 91: 943-949. 10.1093/jnci/91.11.943.CrossRefPubMed
6.
go back to reference The Anglian Breast Cancer Study Group: Prevalence of BRCA1 and BRCA2 mutations in a large population based series of breast cancer cases. Br J Cancer. 2000, 83: 1301-1308. 10.1054/bjoc.2000.1407.CrossRef The Anglian Breast Cancer Study Group: Prevalence of BRCA1 and BRCA2 mutations in a large population based series of breast cancer cases. Br J Cancer. 2000, 83: 1301-1308. 10.1054/bjoc.2000.1407.CrossRef
7.
go back to reference Easton DF: How many more breast cancer predisposition genes are there?. Breast Cancer Res. 1999, 1: 1-4. 10.1186/bcr6.CrossRef Easton DF: How many more breast cancer predisposition genes are there?. Breast Cancer Res. 1999, 1: 1-4. 10.1186/bcr6.CrossRef
8.
go back to reference Peto J, Mack TM: High constant incidence in twins and other relatives of women with breast cancer. Nat Genet. 2000, 26: 411-414. 10.1038/82533.CrossRefPubMed Peto J, Mack TM: High constant incidence in twins and other relatives of women with breast cancer. Nat Genet. 2000, 26: 411-414. 10.1038/82533.CrossRefPubMed
9.
go back to reference Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K: Environmental and heritable factors in the causation of cancer – analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000, 343: 78-85. 10.1056/NEJM200007133430201.CrossRefPubMed Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K: Environmental and heritable factors in the causation of cancer – analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000, 343: 78-85. 10.1056/NEJM200007133430201.CrossRefPubMed
10.
go back to reference Cui J, Antoniou AC, Dite GS, Southey MC, Venter DJ, Easton DF, Giles GG, McCredie MRE, Hopper JL: After BRCA1 and BRCA2 – what next? Multifactorial segregation analysis of three-generational, population-based Australian female breast cancer families. Am J Hum Genet. 2000, 68: 420-431. 10.1086/318187.CrossRefPubMedPubMedCentral Cui J, Antoniou AC, Dite GS, Southey MC, Venter DJ, Easton DF, Giles GG, McCredie MRE, Hopper JL: After BRCA1 and BRCA2 – what next? Multifactorial segregation analysis of three-generational, population-based Australian female breast cancer families. Am J Hum Genet. 2000, 68: 420-431. 10.1086/318187.CrossRefPubMedPubMedCentral
11.
go back to reference Ottman R, Pike MC, King M-C, Casagrande JT, Henderson BE: Familial breast cancer in a population based series. Am J Epidemiol. 1986, 123: 15-21.PubMed Ottman R, Pike MC, King M-C, Casagrande JT, Henderson BE: Familial breast cancer in a population based series. Am J Epidemiol. 1986, 123: 15-21.PubMed
12.
go back to reference Antoniou AC, Pharoah PDP, McMullen G, Day NE, Ponder BAJ, Easton DF: Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population based study. Genet Epidemiol. 2001, 21: 1-18. 10.1002/gepi.1014.CrossRefPubMed Antoniou AC, Pharoah PDP, McMullen G, Day NE, Ponder BAJ, Easton DF: Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population based study. Genet Epidemiol. 2001, 21: 1-18. 10.1002/gepi.1014.CrossRefPubMed
13.
go back to reference Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, Isaacs C, Olopade O, Garber JE, Godwin AK, Daly MB, Narod SA, Neuhausen SL, Lynch HT, Weber BL: Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst. 1999, 91: 1475-1479. 10.1093/jnci/91.17.1475.CrossRefPubMed Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, Isaacs C, Olopade O, Garber JE, Godwin AK, Daly MB, Narod SA, Neuhausen SL, Lynch HT, Weber BL: Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst. 1999, 91: 1475-1479. 10.1093/jnci/91.17.1475.CrossRefPubMed
14.
go back to reference Narod SA, Goldgar D, Cannon-Albright L, Weber B, Moslehi R, Ives E, Lenoir G, Lynch H: Risk modifiers in carriers of BRCA1 mutations. Int J Cancer. 1995, 20: 394-398.CrossRef Narod SA, Goldgar D, Cannon-Albright L, Weber B, Moslehi R, Ives E, Lenoir G, Lynch H: Risk modifiers in carriers of BRCA1 mutations. Int J Cancer. 1995, 20: 394-398.CrossRef
15.
go back to reference Jernstrom H, Lerman C, Ghadirian P, Lynch HT, Weber B, Garber J, Daly M, Olopade OI, Foulkes WD, Warner E, Brunet JS, Narod SA: Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet. 1999, 354: 1846-1850. 10.1016/S0140-6736(99)04336-6.CrossRefPubMed Jernstrom H, Lerman C, Ghadirian P, Lynch HT, Weber B, Garber J, Daly M, Olopade OI, Foulkes WD, Warner E, Brunet JS, Narod SA: Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet. 1999, 354: 1846-1850. 10.1016/S0140-6736(99)04336-6.CrossRefPubMed
Metadata
Title
Familial risks of breast cancer
Author
Douglas F Easton
Publication date
01-10-2002
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 5/2002
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr448

Other articles of this Issue 5/2002

Breast Cancer Research 5/2002 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine